Publications of Kenneth G. Cornetta - IUSM ReSEARCH Connect

150 Publications

This view shows all the publications associated to this researcher. Select a tab to view the documents within each secion. If you are an authorized user, you can add content by selecting the Edit your profile button above. Access to this tool is managed by a project team at your institution.

Jump to:

Books
Book Chapters
Conference Proceedings
Meeting Abstracts
Presentations
Technical Reports
Other Written Works

150 Publications From Scopus

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

Jacques P. Tremblay; Xiao Xiao; Annemieke Aartsma-Rus; Carlos Barbas; Helen M. Blau; Adam J. Bogdanove; Kym Boycott; Serge Braun; Xandra O. Breakefield; Juan A. Bueren; et al.

Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases
Molecular Therapy. 2013;21(2):266-268.

0
2.
2013

A.L. Aloia; L. Duffy; V. Pak; K.E. Lee; S. Sanchez-Martinez; D. Derse; G. Heidecker; K. Cornetta; A. Rein

A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay
Gene Therapy. 2013;20(2):169-176.

0
3.
2013

Kenneth Cornetta; Candy Gunther Brown

Balancing personalized medicine and personalized care
Academic Medicine. 2013;88(3):309-313.

0
4.
2013

Sherif S. Farag; Shivani Srivastava; Steven Messina-Graham; Jennifer Schwartz; Michael J. Robertson; Rafat Abonour; Kenneth Cornetta; Lisa Wood; Angie Secrest; R. Matthew Strother; et al.

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies
Stem Cells and Development. 2013;22(7):1007-1015.

0
5.
2012

Adham S. Bear; Richard A. Morgan; Kenneth Cornetta; Carl H. June; Gwendolyn Binder-Scholl; Mark E. Dudley; Steven A. Feldman; Steven A. Rosenberg; Sheila A. Shurtleff; Cliona M. Rooney; et al.

Replication-competent retroviruses in gene-modified T cells used in clinical trials: Is it time to revise the testing requirements?
Molecular Therapy. 2012;20(2):246-249.

4
6.
2012

Anna Leath; Kenneth Cornetta

Developing novel lentiviral vectors into clinical products
Methods in Enzymology. 2012;507:89-108.

1
7.
2012

Scott R. Witting; Lin-Hong Li; Aparna Jasti; Cornell Allen; Kenneth Cornetta; James Brady; Rama Shivakumar; Madhusudan V. Peshwa

Efficient large volume lentiviral vector production using flow electroporation
Human Gene Therapy. 2012;23(2):243-249.

3
8.
2012

Kenneth Cornetta; Kimberly Tessanne; Charles Long; Jing Yao; Carey Satterfield; Mark Westhusin

Transgenic sheep generated by lentiviral vectors: safety and integration analysis of surrogates and their offspring
Transgenic Research. 2012:1-9.

0
9.
2012

Aaron Shaw; Daniela Bischof; Aparna Jasti; Aaron Ernstberger; Troy Hawkins; Kenneth Cornetta

Using Pulmozyme DNase treatment in lentiviral vector production.
Human gene therapy methods. 2012;23(1):65-71.

0
10.
2011

Steven A. Feldman; Stephanie L. Goff; Hui Xu; Mary A. Black; James N. Kochenderfer; Laura A. Johnson; James C. Yang; Qiong Wang; Maria R. Parkhurst; Scott Cross; et al.

Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells
Human Gene Therapy. 2011;22(1):107-115.

2
11.
2011

Troy B. Hawkins; Jessica Dantzer; Brandon Peters; Mary Dinauer; Keithanne Mockaitis; Sean Mooney; Kenneth Cornetta

Identifying viral integration sites using SeqMap 2.0
Bioinformatics. 2011;27(5):720-722.

8
12.
2011

Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A. Couture; Troy Hawkins; Lisa Duffy

Replication-competent lentivirus analysis of clinical grade vector products
Molecular Therapy. 2011;19(3):557-566.

5
13.
2011

Hal E. Broxmeyer; Man-Ryul Lee; Giao Hangoc; Scott Cooper; Nutan Prasain; Young-June Kim; Coleen Mallett; Zhaohui Ye; Scott Witting; Kenneth Cornetta; et al.

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood
Blood. 2011;117(18):4773-4777.

20
14.
2011

Lindsay L. Rosenbeck; Patrick J. Kiel; Iftekhar Kalsekar; Craig Vargo; John Baute; Cheryl K. Sullivan; Lisa Wood; Sahar Abdelqader; Jennifer Schwartz; Shivani Srivastava; et al.

Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation. 2011;17(6):916-922.

4
15.
2011

Juan Fang; Eric S. Jensen; Mary K. Boudreaux; Lily M. Du; Troy B. Hawkins; Sevasti B. Koukouritaki; Kenneth Cornetta; David A. Wilcox

Platelet gene therapy improves hemostatic function for integrin αIIbβ3-deficient dogs
Proceedings of the National Academy of Sciences of the United States of America. 2011;108(23):9583-9588.

6
16.
2010

Qingwen Jin; Bashar Alkhatib; Kenneth Cornetta; Ghalib Alkhatib

Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1
Virology. 2010;396(2):203-212.

9
17.
2010

Tao Geng; Yihong Zhan; Hsiang-Yu Wang; Scott R. Witting; Kenneth G. Cornetta; Chang Lu

Flow-through electroporation based on constant voltage for large-volume transfection of cells
Journal of Controlled Release. 2010;144(1):91-100.

19
18.
2010

Daniela Bischof; Kenneth Cornetta

Flexibility in cell targeting by pseudotyping lentiviral vectors.
Methods in molecular biology (Clifton, N.J.). 2010;614:53-68.

4
19.
2010

Ken Cornetta

Editorial: 2010 gene therapy year in review
Molecular Therapy. 2010;18(8):1417-1418.

1
20.
2010

R.P. Nelson; M. Yu; J.E. Schwartz; M.J. Robertson; R. Hromas; C.A. Fausel; G.H. Vance; S.R. Dlouhy; J.A. Baute; E.A. Cox; et al.

Long-term disease-free survival after nonmyeloablative cyclophosphamide/ fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia
Bone Marrow Transplantation. 2010;45(8):1300-1308.

5
21.
2010

Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; et al.

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Nature. 2010;467(7313):318-322.

195
22.
2010

Daniel P. Heruth; Troy Hawkins; Derek P. Logsdon; Margaret I. Gibson; Inna V. Sokolovsky; Ndona N. Nsumu; Stephanie L. Major; Barbara Fegley; Gerald M. Woods; Karen B. Lewing; et al.

Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model
Genomics. 2010;96(5):303-307.

10
23.
2010

Sung P. Ha; Nicholas D. Klemen; Garrett H. Kinnebrew; Andrew G. Brandmaier; Jon Marsh; Giao Hangoc; Douglas C. Palmer; Nicholas P. Restifo; Kenneth Cornetta; Hal E. Broxmeyer; et al.

Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity
Journal of Clinical Investigation. 2010;120(12):4273-4288.

13
24.
2009

Lakshmi Sastry; Kenneth Cornetta

Detection of replication competent retrovirus and lentivirus.
Methods in molecular biology (Clifton, N.J.). 2009;506:243-263.

3
25.
2009

Kenneth Cornetta; Lorraine Matheson

The national gene vector biorepository's pharm/tox database
Molecular Therapy. 2009;17(4):582-584.

0
26.
2009

M.A. Sadat; S. Dirscherl; L. Sastry; J. Dantzer; N. Pech; S. Griffin; T. Hawkins; Y. Zhao; C.N. Barese; S. Cross; et al.

Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation
Gene Therapy. 2009;16(12):1452-1464.

5
27.
2009

Tao Geng; Yihong Zhan; Hsiang-Yu Wang; Scott R. Witting; Kenneth G. Cornetta; Chang Lu

Flow-through electroporation for large-volume transfection of cells
AIChE Annual Meeting, Conference Proceedings. 2009.

0
28.
2008

Kenneth Cornetta; Lilith Reeves; Scott Cross

Production of retroviral vectors for clinical use
Methods in Molecular Biology. 2008;433:17-32.

1
29.
2008

Kenneth Cornetta; Karen E. Pollok; A. Dusty Miller

Retroviral vectors for gene transfer
Cold Spring Harbor Protocols. 2008;3(4).

1
30.
2008

Kenneth Cornetta; Karen E. Pollok; A. Dusty Miller

Generation of stable vector-producing cells for retroviral vectors
Cold Spring Harbor Protocols. 2008;3(4).

0
31.
2008

Kenneth Cornetta; Karen E. Pollok; A. Dusty Miller

Transduction of primary hematopoietic cells by retroviral vectors
Cold Spring Harbor Protocols. 2008;3(4).

0
32.
2008

Kenneth Cornetta; Karen E. Pollok; A. Dusty Miller

Transduction of cell lines by retroviral vectors
Cold Spring Harbor Protocols. 2008;3(4).

0
33.
2008

Kenneth Cornetta; Karen E. Pollok; A. Dusty Miller

Retroviral vector production by transient transfection
Cold Spring Harbor Protocols. 2008;3(4).

0
34.
2008

B. Peters; S. Dirscherl; J. Dantzer; J. Nowacki; S. Cross; X. Li; K. Cornetta; M.C. Dinauer; S.D. Mooney

Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource
Gene Therapy. 2008;15(18):1294-1298.

5
35.
2008

Qingwen Jin; Jon Marsh; Kenneth Cornetta; Ghalib Alkhatib

Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5Δ32 gene despite detectable expression of the HIV-1 co-receptors
Journal of General Virology. 2008;89(10):2611-2621.

5
36.
2008

Kang Chu; Kenneth G. Cornetta; Michael J. Econs

Efficient and stable gene expression into human osteoclasts using an HIV-1-based lentiviral vector
DNA and Cell Biology. 2008;27(6):315-320.

4
37.
2007

Wen Tao; Barbara-Graham Evans; Jing Yao; Scott Cooper; Kenneth Cornetta; Christopher B. Ballas; Giao Hangoc; Hal E. Broxmeyer

Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-Express fluorescent protein is not
Stem Cells. 2007;25(3):670-678.

18
38.
2007

Lisa Brannon-Peppas; Bilal Ghosn; Krishnendu Roy; Kenneth Cornetta

Encapsulation of nucleic acids and opportunities for cancer treatment
Pharmaceutical Research. 2007;24(4):618-627.

14
39.
2007

Cary Hsu; Stephanie A. Jones; Cyrille J. Cohen; Zhili Zheng; Keith Kerstann; Juhua Zhou; Paul F. Robbins; Peter D. Peng; Xinglei Shen; Theotonius J. Gomes; et al.

Cytokine-independent growth and clonal expansion of a primary human CD8⁺ T-cell clone following retroviral transduction with the IL-15 gene
Blood. 2007;109(12):5168-5177.

24
40.
2007

Liying Cai; Brian H. Johnstone; Todd G. Cook; Zhong Liang; Dmitry Traktuev; Kenneth Cornetta; David A. Ingram; Elliot D. Rosen; Keith L. March

Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization
Stem Cells. 2007;25(12):3234-3243.

62
41.
2006

Kristin M. Hall; Tamara L. Horvath; Rafat Abonour; Kenneth Cornetta; Edward F. Srour

Decreased homing of retrovirally transduced human bone marrow CD34 ⁺ cells in the NOD/SCID mouse model
Experimental Hematology. 2006;34(4):433-442.

12
42.
2006

K. Cornetta; J. Croop; E. Dropcho; R. Abonour; M.W. Kieran; S. Kreissman; L. Reeves; L.C. Erickson; D.A. Williams

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase
Cancer Gene Therapy. 2006;13(9):886-895.

13
43.
2006

Robert P. Nelson Jr.; Kenneth Cornetta; Kelly E. Ward; Srinivasan Ramanuja; Chris Fausel; Larry D. Cripe

Desensitization to imatinib in patients with leukemia
Annals of Allergy, Asthma and Immunology. 2006;97(2):216-222.

7
44.
2006

Shangming Zhang; Guiandre Joseph; Karen Pollok; Lionel Berthoux; Lakshmi Sastry; Jeremy Luban; Kenneth Cornetta

G2 Cell Cycle Arrest and Cyclophilin A in Lentiviral Gene Transfer
Molecular Therapy. 2006;14(4):546-554.

4
45.
2005

Kenneth Cornetta; Mary Laughlin; Shelly Carter; Donna Wall; Joel Weinthal; Colleen Delaney; John Wagner; Robert Sweetman; Philip McCarthy; Nelson Chao

Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT)
Biology of Blood and Marrow Transplantation. 2005;11(2):149-160.

76
46.
2005

Lakshmi Sastry; Yi Xu; Lisa Duffy; Sue Koop; Aparna Jasti; Holger Roehl; Doug Jolly; Kenneth Cornetta

Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection
Human Gene Therapy. 2005;16(10):1227-1236.

15
47.
2005

Christoph A. Kahl; Karen Pollok; Laura S. Haneline; Kenneth Cornetta

Lentiviral vectors pseudotyped with glycoproteins from ross river and vesicular stomatitis viruses: Variable transduction related to cell type and culture conditions
Molecular Therapy. 2005;11(3):470-482.

9
48.
2005

Anthony D. Villella; Jing Yao; Robert R. Getty; Beth E. Juliar; Constantin Yiannoutsos; Jennifer R. Hartwell; Shanbao Cai; Mohammed A. Sadat; Kenneth Cornetta; David A. Williams; et al.

Real-Time PCR: An effective tool for measuring transduction efficiency in human hematopoietic progenitor cells
Molecular Therapy. 2005;11(3):483-491.

6
49.
2005

Michael J. Robertson; Rafat Abonour; Robert Hromas; Robert P. Nelson Jr.; Naomi S. Fineberg; Kenneth Cornetta

Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma
Leukemia and Lymphoma. 2005;46(10):1477-1487.

6
50.
2005

K. Cornetta; L. Matheson; C. Ballas

Retroviral vector production in the National Gene Vector Laboratory at Indiana University
Gene Therapy. 2005;12(SUPPL. 1):S28-S35.

10
51.
2004

Christoph A. Kahl; Jon Marsh; Joanne Fyffe; David A. Sanders; Kenneth Cornetta

Human Immunodeficiency Virus Type 1-Derived Lentivirus Vectors Pseudotyped with Envelope Glycoproteins Derived from Ross River Virus and Semliki Forest Virus
Journal of Virology. 2004;78(3):1421-1430.

32
52.
2004

Lakshmi Sastry; Yi Xu; Ryan Cooper; Karen Pollok; Kenneth Cornetta

Evaluation of Plasmid DNA Removal from Lentiviral Vectors by Benzonase Treatment
Human Gene Therapy. 2004;15(2):221-226.

26
53.
2003

Kenneth Cornetta

Regulatory issues in human gene therapy
Blood Cells, Molecules, and Diseases. 2003;31(1):51-56.

4
54.
2003

Lakshmi Sastry; Yi Xu; Terry Johnson; Kunal Desai; David Rissing; Jonathan Marsh; Kenneth Cornetta

Certification assays for HIV-1-based vectors: Frequent passage of gag sequences without evidence of replication-competent viruses
Molecular Therapy. 2003;8(5):830-839.

29
55.
2003

Donald B. Kohn; Michel Sadelain; Cynthia Dunbar; David Bodine; Hans-Peter Kiem; Fabio Candotti; John Tisdale; Isabelle Riviére; C. Anthony Blau; Robert E. Richard; et al.

American Society of Gene Therapy (ASGT) Ad Hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells
Molecular Therapy. 2003;8(2):180-187.

113
56.
2002

Kenneth Cornetta; Franklin O. Smith

Regulatory issues for clinical gene therapy trials
Human Gene Therapy. 2002;13(10):1143-1149.

16
57.
2002

Lilith Reeves; Lisa Duffy; Sue Koop; Joanne Fyffe; Kenneth Cornetta

Detection of ecotropic replication-competent retroviruses: Comparison of S⁺/L^- and marker rescue assays
Human Gene Therapy. 2002;13(14):1783-1790.

9
58.
2002

L. Sastry; T. Johnson; M.J. Hobson; B. Smucker; K. Cornetta

Titering lentiviral vectors: Comparison of DNA, RNA and marker expression methods
Gene Therapy. 2002;9(17):1155-1162.

133
59.
2002

G.M. Vail; R.S. Young; L.J. Wheat; R.S. Filo; K. Cornetta; M. Goldman

Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area
Transplant Infectious Disease. 2002;4(3):148-151.

48
60.
2002

Nicolas Mermod; Kenneth Cornetta

Gene transfer: The ins, the outs... and the next generation
Current Opinion in Biotechnology. 2002;13(5):415-417.

0
61.
2002

Michael J. Robertson; David Pelloso; Rafat Abonour; Robert A. Hromas; Robert P. Nelson Jr.; Lisa Wood; Kenneth Cornetta

Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies
Clinical Cancer Research. 2002;8(11):3383-3393.

20
62.
2002

John E. Levine; Thomas Braun; Samuel L. Penza; Patrick Beatty; Kenneth Cornetta; Rodrigo Martino; William R. Drobyski; A. John Barrett; David L. Porter; Sergio Giralt; et al.

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
Journal of Clinical Oncology. 2002;20(2):405-412.

115
63.
2001

A.K. Siston; M.A. List; C.K. Daugherty; D.M. Banik; C. Menke; K. Cornetta; R.A. Larson

Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation
Bone Marrow Transplantation. 2001;27(11):1181-1188.

27
64.
2001

Emiko L. Kreklau; Naili Liu; Zhaohua Li; Kenneth Cornetta; Leonard C. Erickson

Comparison of single- versus double-bolus treatments of O⁶-benzylguanine for depletion of O⁶-methylguanine DNA methyltransferase (MGMT) activity in vivo: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity
Journal of Pharmacology and Experimental Therapeutics. 2001;297(2):524-530.

19
65.
2001

N. Hanna; V.S. Gharpure; R. Abonour; K. Cornetta; P.J. Loehrer Sr.

High-dose carboplatin with etoposide in patients with recurrent thymoma: The Indiana University experience
Bone Marrow Transplantation. 2001;28(5):435-438.

17
66.
2001

J. Chen; L. Reeves; K. Cornetta

Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors
Human Gene Therapy. 2001;12(1):61-70.

25
67.
2001

Jun Chen; Lilith Reeves; Nathan Sanburn; James Croop; David A. Williams; Kenneth Cornetta

Packaging cell line DNA contamination of vector supernatants: Implication for laboratory and clinical research
Virology. 2001;282(1):186-197.

30
68.
2001

Rafat Abonour; Merrill D. Benson; Michael J. Robertson; Hromas A. Robert; Cornetta Kenneth

Tandem intermediate dose melphalan supported by autologous progenitor cells in the management of primary amyloidosis
Blood. 2001;96(11 PART II):367b.

1
69.
2001

Sudhanshu P. Raikwar; Kenneth Cornetta

Ganciclovir mediated killing of t cells transduced with vsv-g pseudotyped lentiviral vector expressing HSVTK
Blood. 2001;96(11 PART II):383b.

0
70.
2000

J.M. Croop; R. Cooper; R. Seshadri; C. Fernandez; V. Graves; S. Kreissman; F.O. Smith; K. Cornetta; D.A. Williams; R. Abonour

Large-scale mobilization and isolation of CD34⁺ cells from normal donors
Bone Marrow Transplantation. 2000;26(12):1271-1279.

10
71.
2000

W. Bensinger; K. Cornetta; M. Carabasi; S. Yanovich; T. Hughes; B. Skikne; C. Chabannon; S. Singhal; B. Mills

T cell depleted allogeneic PBSC transplantation using CD34+ cell selection
Blood. 2000;96(11 PART I):198a.

1
72.
2000

Abing Wang; Stephen E. Braun; Guru Sonpavde; Kenneth Cornetta

Antileukemic activity of Flt3 ligand in murine leukemia
Cancer Research. 2000;60(7):1895-1900.

21
73.
2000

Betsy L. Fife; Gertrude A. Huster; Kenneth G. Cornetta; Victoria N. Kennedy; Luke P. Akard; E. Randolph Broun

Longitudinal study of adaptation to the stress of bone marrow transplantation
Journal of Clinical Oncology. 2000;18(7):1539-1549.

77
74.
2000

S. Yanovich; P. Mitsky; K. Cornetta; R.T. Maziarz; C. Rosenfeld; D.S. Krause; J.-P. Lotz; J.D. Bitran; S. Williams; R. Preti; et al.

Transplantation of CD34⁺ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: Results of a prospective randomized multicenter clinical trial
Bone Marrow Transplantation. 2000;25(11):1165-1174.

19
75.
2000

Rafat Abonour; David A. Williams; Lawrence Einhorn; Kristin M. Hall; Jun Chen; John Coffman; Christie M. Traycoff; Arthur Bank; Ikunoshin Kato; Maureen Ward; et al.

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
Nature Medicine. 2000;6(6):652-658.

205
76.
2000

S. Bhatia; R. Abonour; P. Porcu; R. Seshadri; C.R. Nichols; K. Cornetta; L.H. Einhorn

High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer
Journal of Clinical Oncology. 2000;18(19):3346-3351.

103
77.
2000

L. Reeves; K. Cornetta

Clinical retroviral vector production: Step filtration using clinically approved filters improves titers
Gene Therapy. 2000;7(23):1993-1998.

19
78.
2000

S.A. Rosenberg; R.M. Blaese; M.K. Brenner; A.B. Deisseroth; F.D. Ledley; M.T. Lotze; J.M. Wilson; G.J. Nabel; K. Cornetta; J.S. Economou; et al.

Human gene marker/therapy clinical protocols.
Human gene therapy. 2000;11(6):919-979.

31
79.
2000

L. Reeves; P. Smucker; K. Cornetta

Packaging cell line characteristics and optimizing retroviral vector titer: The national gene vector laboratory experience
Human Gene Therapy. 2000;11(15):2093-2103.

29
80.
2000

Stephen E. Braun; Keyue Chen; Richard G. Foster; Chang H. Kim; Robert Hromas; Mark H. Kaplan; Hal E. Broxmeyer; Kenneth Cornetta

The CC chemokine CKβ-11/MIP-3β/ELC/exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells
Journal of Immunology. 2000;164(8):4025-4031.

96
81.
2000

Harikrishna Nakshatri; Marc S. Mendonca; Poornima Bhat-Nakshatri; Nikhil M. Patel; Robert J. Goulet Jr.; Kenneth Cornetta

The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2
Biochemical and Biophysical Research Communications. 2000;270(3):1144-1153.

19
82.
1999

N. Sanburn; K. Cornetta

Rapid titer determination using quantitative real-time PCR
Gene Therapy. 1999;6(7):1340-1345.

39
83.
1999

R.E. Pyatt; L.L. Jenski; R. Allen; K. Cornetta; R. Abonour; C.M. Traycoff; E.F. Srour

Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells
Journal of Hematotherapy. 1999;8(2):189-198.

2
84.
1999

E.F. Srour; R. Abonour; K. Cornetta; C.M. Traycoff

Ex vivo expansion of hematopoietic stem and progenitor cells: Are we there yet?
Journal of Hematotherapy. 1999;8(2):93-102.

45
85.
1999

Stephen E. Braun; Keyue Chen; Bruce R. Blazar; Paul J. Orchard; George Sledge; Michael J. Robertson; Hal E. Broxmeyer; Kenneth Cornetta

Flt3 ligand antitumor activity in a murine breast cancer model: A comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action
Human Gene Therapy. 1999;10(13):2141-2151.

32
86.
1999

S.A. Rosenberg; R.M. Blaese; M.K. Brenner; A.B. Deisseroth; F.D. Ledley; M.T. Lotze; J.M. Wilson; G.J. Nabel; K. Cornetta; J.S. Economou; et al.

Human gene marker/therapy clinical protocols.
Human gene therapy. 1999;10(18):3067-3123.

28
87.
1999

P.S. Smucker; K. Cornetta

Growth characteristics of common retroviral packaging cells
Journal of Investigative Medicine. 1999;47(2):12A.

0
88.
1998

K. Cornetta; V. Gharpure; B. Mills; R. Hromas; R. Abonour; E.R. Broun; C.M. Traycoff; M. Hanna; N. Wyman; C. Danielson; et al.

Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells
Bone Marrow Transplantation. 1998;21(1):65-71.

20
89.
1998

C. Chabannon; K. Cornetta; J.-P. Lotz; C. Rosenfeld; M. Shlomchik; S. Yanovitch; J.-P. Marolleau; G. Sledge; G. Novakovitch; E.F. Srour; et al.

High-dose chemotherapy followed by reinfusion of selected CD34⁺ peripheral blood cells in patients with poor-prognosis breast cancer: A randomized multicentre study
British Journal of Cancer. 1998;78(7):913-921.

25
90.
1998

R. Abonour; K.M. Scott; L.A. Kunkel; M.J. Robertson; R. Hromas; V. Graves; E.N. Lazaridis; L. Cripe; V. Gharpure; C.M. Traycoff; et al.

Autologous transplantation of mobilized peripheral blood CD34⁺ cells selected by immunomagnetic procedures in patients with multiple myeloma
Bone Marrow Transplantation. 1998;22(10):957-963.

37
91.
1998

R.I. Jakacki; C. Jamison; V.P. Mathews; D.K. Hellman; E. Dropcho; K. Cornetta; D.R. Macdonald; D.A. Williams

Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas
Medical and Pediatric Oncology. 1998;31(6):483-490.

13
92.
1998

Michael Fisch; Frederick Unverzagt; Mark Hanna; Patricia Bledsoe; Catherine Menke; Kenneth Cornetta

Information preferences, reading ability, and emotional changes in outpatients during the process of obtaining informed consent for autologous bone-marrow transplantation
Journal of Cancer Education. 1998;13(2):71-75.

6
93.
1998

Christie M. Traycoff; Bartley Halstead; Susan Rice; Jon Mcmahel; Edward F. Srour; Kenneth Cornetta

Chronic myelogenous leukaemia CD34⁺ cells exit G₀/G₁ phases of cell cycle more rapidly than normal marrow CD34⁺ cells
British Journal of Haematology. 1998;102(3):759-767.

32
94.
1998

Yi Fan; Lawrence Einhorn; Scott Saxman; Barry Katz; Rafat Abonour; Kenneth Cornetta

Detection of germ cell tumor cells in apheresis products using polymerase chain reaction
Clinical Cancer Research. 1998;4(1):93-98.

14
95.
1998

Steven H. Bernstein; Auayporn P. Nademanee; Julie M. Vose; Guido Tricot; Joseph W. Fay; Robert S. Negrin; John DiPersio; Gabriela Rondon; Richard Champlin; Michael J. Barnett; et al.

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation
Blood. 1998;91(9):3509-3517.

72
96.
1998

A. Balduini; S.E. Braun; K. Cornetta; S. Lyman; H.E. Broxmeyer

Comparative effects of retroviral-mediated gene transfer into primary human stromal cells of Flt3-ligand, interleukin 3 and GM-CSF on production of cord blood progenitor cells in long-term culture.
Stem cells (Dayton, Ohio). 1998;16 Suppl 1:37-49.

3
97.
1998

Kenneth G. Lucas; Robert L. Burton; Sarah E. Zimmerman; Jinghong Wang; Kenneth G. Cornetta; Kent A. Robertson; Chao H. Lee; David J. Emanuel

Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation
Blood. 1998;91(10):3654-3661.

157
98.
1998

Ponnazhagan Veena; Christie M. Traycoff; David A. Williams; Jon McMahel; Susan Rice; Ken Cornetta; Edward F. Srour

Delayed targeting of cytokine-nonresponsive human bone marrow CD34⁺ cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes
Blood. 1998;91(10):3693-3701.

15
99.
1997

S.E. Braun; K. Chen; M. Battiwalla; K. Cornetta

Gene therapy strategies for leukemia
Molecular Medicine Today. 1997;3(1):39-46.

6
100.
1997

Stephen E. Braun; R. Scott Mclvor; Amy S. Davidson; Mark Hanna; Christie M. Traycoff; Doug A. Berebetsky; René Gonin; Hal E. Broxmeyer; Kenneth Cornetta

Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: A comparison of methotrexate resistance
Cancer Gene Therapy. 1997;4(1):26-32.

6
101.
1997

P. Veena; K. Cornetta; A. Davidson; B. Agüero; J. McMahel; C.M. Traycoff; E.F. Srour

Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34⁺ cells
Bone Marrow Transplantation. 1997;19(12):1213-1221.

7
102.
1997

E. Randolph Broun; Craig R. Nichols; Gary Gize; Kenneth Cornetta; Robert A. Hromas; Brenda Schacht; Lawrence H. Einhorn

Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer
Cancer. 1997;79(8):1605-1610.

71
103.
1997

C.M. Traycoff; E.F. Srour; P. Dutt; Y. Fan; K. Cornetta

The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors
Leukemia. 1997;11(1):159-167.

16
104.
1997

Kenneth Cornetta; Yi Fan

Retroviral gene therapy in hematopoietic diseases
Journal of Clinical Apheresis. 1997;12(4):187-193.

3
105.
1997

S.A. Rosenberg; R.M. Blaese; M.K. Brenner; A.B. Deisseroth; F.D. Ledley; M.T. Lotze; J.M. Wilson; G.J. Nabel; K. Cornetta; J.S. Economou; et al.

Human gene marker/therapy clinical protocols.
Human gene therapy. 1997;8(18):2301-2338.

20
106.
1997

Keyue Chen; Stephen Braun; Stewart Lyman; Yi Fan; Christie M. Traycoff; Eric A. Wiebke; Jay Gaddy; George Sledge; Hal E. Broxmeyer; Kenneth Cornetta

Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model
Cancer Research. 1997;57(16):3511-3516.

99
107.
1996

Kenneth Cornetta; Edward F. Srour; Ann Moore; Amy Davidson; E. Randolph Broun; Robert Hromas; Robert C. Moen; Richard A. Morgan; Lorraine Rubin; W. French Anderson; et al.

Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia
Human Gene Therapy. 1996;7(11):1323-1329.

23
108.
1996

V. Gharpure; L. Rubin; J. Amlin; D. Emanuel; W. Schroeder; A. Davidson; R. Hromas; K. Cornetta

Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease
Bone Marrow Transplantation. 1996;18(1):221-224.

1
109.
1996

L.J. McCarthy; C. Danielson; A. Orazi; E. Skipworth; L. Jackson; V. Graves; V. Gharpure; K. Cornetta

Platelet loss during peripheral blood progenitor cell collections
Transfusion Science. 1996;17(3):475.

0
110.
1996

C.M. Traycoff; K. Cornetta; M.C. Yoder; A. Davidson; E.F. Srour

Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential
Experimental Hematology. 1996;24(2):299-306.

85
111.
1996

R. Hromas; S. Boswell; R.-N. Shen; G. Burgess; A. Davidson; K. Cornetta; J. Sutton; K. Robertson

Forced over-expression of the myeloid zinc finger gene MZF-1 inhibits apoptosis and promotes oncogenesis in interleukin-3-dependent FDCP.1 cells
Leukemia. 1996;10(6):1049-1050.

14
112.
1996

S.A. Rosenberg; R.M. Blaese; M.K. Brenner; A.B. Deisseroth; F.D. Ledley; M.T. Lotze; J.M. Wilson; G.J. Nabel; K. Cornetta; J.S. Economou; et al.

Human gene marker/therapy clinical protocols.
Human gene therapy. 1996;7(18):2287-2313.

14
113.
1996

M. Xiao; Y.-C. Yang; L. Yang; M.-S. Chang; K. Cornetta; H.E. Broxmeyer; L. Lu

Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies
Bone Marrow Transplantation. 1996;18(6):1103-1109.

6
114.
1996

S.A. Rosenberg; R.M. Blaese; M.K. Brenner; A.B. Deisseroth; F.D. Ledley; M.T. Lotze; J.M. Wilson; G.J. Nabel; K. Cornetta; J.S. Economou; et al.

Human gene marker/therapy clinical protocols.
Human gene therapy. 1996;7(13):1621-1647.

11
115.
1996

J.P. Rigden; K. Cornetta; E.F. Srour; M. Hanna; E.R. Broun; R. Hromas; J. Baute; J. Hilton; E. Cox; L. Rubin; et al.

Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation
Bone Marrow Transplantation. 1996;18(5):913-919.

7
116.
1995

E.R. Broun; G.W. Sledge; D. Loesch; K. Cornetta; R. Hromas; P. Kneebone; C. Lottich; T.R. Schmidt; L.H. Einhorn

Two cycles of high dose chemotherapy with autologous bone marrow support for patients with locally advanced breast cancer
Breast Journal. 1995;1(5):308-314.

0
117.
1995

L.J. McCarthy; C.F.M. Danielson; K. Cornetta; E.F. Srour; E.R. Broun

Autologous bone marrow transplantation
Critical Reviews in Clinical Laboratory Sciences. 1995;32(1):67-119.

2
118.
1995

Charles Blanke; Cari Clark; Randolph Broun; Guido Tricot; Isabel Cunningham; Kenneth Cornetta; Ann Hedderman; Robert Hromas

Evolving pathogens in allogeneic bone marrow transplantation: Increased fatal adenoviral infections
The American Journal of Medicine. 1995;99(3):326-328.

58
119.
1995

E.R. Broun; R. Sridhara; G.W. Sledge; D. Loesch; P.H. Kneebone; M. Hanna; R. Hromas; K. Cornetta; L.H. Einhorn

Tandem autotransplantation for the treatment of metastatic breast cancer
Journal of Clinical Oncology. 1995;13(8):2050-2055.

42
120.
1995

R. Hromas; J. Morris; K. Cornetta; D. Berebitsky; A. Davidson; M. Sha; G. Sledge; F. Rauscher III

Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic
Cancer Research. 1995;55(16):3610-3614.

31
121.
1995

E.R. Broun; C.R. Nichols; R. Mandanas; D. Salzman; M. Turns; R. Hromas; K. Cornetta; L.H. Einhorn

Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors
Bone Marrow Transplantation. 1995;16(3):353-358.

22
122.
1995

H.E. Broxmeyer; S. Cooper; N. Hague; L. Benninger; A. Sarris; K. Cornetta; S. Vadhan-Raj; P. Hendrie; C. Mantel

Human chemokines: Enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice
Annals of Hematology. 1995;71(5):235-246.

53
123.
1994

R. Hromas; R. Clark; C. Blanke; G. Tricot; K. Cornetta; A. Hedderman; E.R. Broun

Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation [1]
Bone Marrow Transplantation. 1994;14(4):663-664.

30
124.
1994

K. Cornetta; A. Moore; M. Johannessohn; G.W. Sledge

Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice
Clinical and Experimental Metastasis. 1994;12(1):3-12.

14
125.
1994

R. Hromas; K. Cornetta; E. Srour; C. Blanke; E.R. Broun

Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [5]
Blood. 1994;84(5):1689-1690.

100
126.
1994

K. Cornetta; A. Moore; T. Leemhuis; R.C. Moen; G. Tricot; D. Leibowitz; R. Hoffman

Retroviral mediated gene transfer in chronic myelogenous leukaemia
British Journal of Haematology. 1994;87(2):308-316.

10
127.
1994

K. Cornetta; D. Berebitsky; M. Behnia; C. Traycoff; E.F. Srour; G.W. Sledge

A retroviral vector expressing human interferon gamma upregulates MHC antigen expression in human breast cancer and leukemia cell lines.
Cancer gene therapy. 1994;1(2):91-98.

10
128.
1994

C.M. Traycoff; R. Hoffman; E.D. Zanjani; K. Cornetta; P. Law; A.M. Gianni; M. Bregni; S. Siena; M.R. Abboud; et al.

Measurement of marrow repopulating potential of human hematopoietic progenitor and stem cells using a fetal sheep model.
Progress in clinical and biological research. 1994;389:281-291.

5
129.
1993

E.F. Srour; E.D. Zanjani; K. Cornetta; C.M. Traycoff; A.W. Flake; M. Hedrick; J.E. Brandt; T. Leemhuis; R. Hoffman

Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep
Blood. 1993;82(11):3333-3342.

72
130.
1993

Kenneth Cornetta; Nga Nguyen; Richard A. Morgan; Daryl D. Muenchau; Janet W. Hartley; R. Michael Blaese; W. French Anderson

Infection of human cells with murine amphotropic replication-competent retroviruses
Human Gene Therapy. 1993;4(5):579-588.

34
131.
1992

K. Cornetta

Safety aspects of gene therapy
British Journal of Haematology. 1992;80(4):421-426.

26
132.
1992

K. Cornetta; G. Tricot; E.R. Broun; R. Hromas; E. Srour; R. Hoffman; W.F. Anderson; R.C. Moen; R.A. Morgan

Retroviral-mediated gene transfer of bone marrow cells during autologous bone marrow transplantation for acute leukemia.
Human gene therapy. 1992;3(3):305-318.

9
133.
1991

Kenneth Cornetta; Richard A. Morgan; Al Gillio; Sabine Sturm; Leon Baltrucki; Richard O'Reilly; W. French Anderson

No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus
Human Gene Therapy. 1991;2(3):215-219.

42
134.
1991

K. Culver; K. Cornetta; R. Morgan; S. Morecki; P. Aebersold; A. Kasid; M. Lotze; S.A. Rosenberg; W.F. Anderson; et al.

Lymphocytes as cellular vehicles for gene therapy in mouse and man
Proceedings of the National Academy of Sciences of the United States of America. 1991;88(8):3155-3159.

64
135.
1991

Shoshana Morecki; Evelyn Karson; Kenneth Cornetta; Attan Kasid; Paul Aebersold; R.Michael Blaese; W.French Anderson; Steven A. Rosenberg

Retrovirus-mediated gene transfer into CD4⁺ and CD8⁺ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells
Cancer Immunology Immunotherapy. 1991;32(6):342-352.

12
136.
1991

R. Wieder; K. Cornetta; S.W. Kessler; W.F. Anderson

Increased efficiency of retroviral-mediated gene transfer and expression in primate bone marrow progenitors after 5-fluorouracil-induced hematopoietic suppression and recovery
Blood. 1991;77(3):448-455.

13
137.
1991

Kenneth Cornetta; Richard A. Morgan; W. French Anderson

Safety issues related to retroviral-mediated gene transfer in humans
Human Gene Therapy. 1991;2(1):5-14.

119
138.
1990

S.A. Rosenberg; P. Aebersold; K. Cornetta; A. Kasid; R.A. Morgan; R. Moen; E.M. Karson; M.T. Lotze; J.C. Yang; S.L. Topalian; et al.

Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
New England Journal of Medicine. 1990;323(9):570-578.

447
139.
1990

Jeanne R. McLachlin; Kenneth Cornetta; Martin A. Eglitis; W. French Anderson

Retroviral-Mediated Gene Transfer
Progress in Nucleic Acid Research and Molecular Biology. 1990;38(C):91-135.

22
140.
1990

J.A. Zwiebel; S.M. Freeman; K. Cornetta; R. Forough; T. Maciag; W.F. Anderson

Recombinant gene expression in human umbilical vein endothelial cells transduced by retroviral vectors
Biochemical and Biophysical Research Communications. 1990;170(1):209-213.

2
141.
1990

A. Kasid; S. Morecki; P. Aebersold; K. Cornetta; K. Culver; S. Freeman; E. Director; M.T. Lotze; R.M. Blaese; et al.

Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man
Proceedings of the National Academy of Sciences of the United States of America. 1990;87(1):473-477.

45
142.
1990

D.D. Muenchau; S.M. Freeman; K. Cornetta; J.A. Zwiebel; W.F. Anderson

Analysis of retroviral packaging lines for generation of replication-competent virus
Virology. 1990;176(1):262-265.

30
143.
1990

Richard A. Morgan; Kenneth Cornetta; W. French Anderson

Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells
Human Gene Therapy. 1990;1(2):135-149.

54
144.
1990

Kenneth W. Culver; Richard A. Morgan; William R. A. Osborne; Robert T. Lee; Deborah Lenschow; Cynthia Able; Kenneth Cornetta; W. French Anderson; R. Michael Blaese

In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys
Human Gene Therapy. 1990;1(4):399-410.

26
145.
1990

Kenneth Cornetta; Robert C. Moen; Kenneth Culver; Richard A. Morgan; Jeanne R. McLachlin; Sabine Sturm; Jane Selegue; William London; R. Michael Blaese; et al.

Amphotropic murine leukemia retrovirus is not an acute pathogen for primates
Human Gene Therapy. 1990;1(1):15-30.

77
146.
1989

K. Cornetta; W.F. Anderson

Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy
Journal of Virological Methods. 1989;23(2):187-194.

57
147.
1989

Kenneth Cornetta; Robert Wieder; W. French Anderson

Gene Transfer into Primates and Prospects for Gene Therapy in Humans
Progress in Nucleic Acid Research and Molecular Biology. 1989;36(C):311-322.

7
148.
1989

J.A. Zwiebel; S.M. Freeman; P.W. Kantoff; K. Cornetta; U.S. Ryan; W.F. Anderson

High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors
Science. 1989;243(4888):220-222.

34
149.
1983

K. Cornetta; S. Zucker

Organ distribution of circulating very low density lipoproteins (VLDL): Fate of hematopoietic growth inhibitory VLDL in the rat
Experimental Hematology. 1983;11(4):275-283.

0
150.
1979

R.M. Lysik; K. Cornetta; J.F. DiStefano; S. Zucker

Bone marrow cytolysis induced by hepatoma, teratocarcinoma, and transformed fibroblasts
Cancer Research. 1979;39(1):30-34.

1

Kenneth G. Cornetta School of Medicine, Medical & Molecular Genetics

Kenneth G. Cornetta

150 Publications

Kenneth G. Cornetta
School of Medicine, Medical & Molecular Genetics